Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy

European Journal of Clinical Pharmacology

Volumn 61, Issue 12, 2005, Pages 893-897

  Doró, Péter ^a   Benko, Ria ^a   Kosik, Edit ^a   Matuz, Mária ^a   Tóth, Katalin ^a   Soós, Gyöngyver ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adherence; Diabetes mellitus; Drug utilization; Oral antihyperglycemic drugs

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; BIGUANIDE; BUFORMIN; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; GLIQUIDONE; METFORMIN; NATEGLINIDE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG UTILIZATION; FEMALE; HUMAN; HUNGARY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, ORAL; ADULT; AGED; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HUMANS; HUNGARY; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; RETROSPECTIVE STUDIES;

EID: 29144530944     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0031-9     Document Type: Article

References (22)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) The global prevalence of diabetes. Estimation for the year 2000 and projection for 2030. Diabetes Care 27:1047-1053
2. International Diabetes Federation (2003) The diabetes atlas. International Diabetes Federation, Brussels
3. Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA (2003) Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque country, Spain. Diabetologia 46:899-909
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
5. Lau DT, Nau DP (2004) Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 27:2149-2153
6. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT (2003) Predictor of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 25:2958-2971
7. Schectman JM, Nadkarni MM, Voss JD (2002) The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25:1015-1021
8. Cramer JA (2004) A systemic review of adherence with medication for diabetes. Diabetes Care 27:1218-1224
9. WHO Collaborating Centre for Drug Statistics Methodology (2004) ATC index with DDDs. Norwegian Institute of Public Health, Oslo
10. Merlo J, Wessling A, Melander A (1996) Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol 50:27-30
11. Hungarian Central Statistical Office (1999) Yearbook of health statistics 1998. Hungarian Central Statistical Office, Budapest
12. Hungarian Central Statistical Office (2000) Yearbook of health statistics 1999. Hungarian Central Statistical Office, Budapest
13. Hungarian Central Statistical Office (2002) Yearbook of health statistics (2001). Hungarian Central Statistical Office, Budapest
14. Hungarian Central Statistical Office (2004) Yearbook of health statistics 2003. Hungarian Central Statistical Office, Budapest
15. British Medical Association and Royal Pharmaceutical Society of Great Britain (2004) British National Formulary 47. Pharmaceutical Press, London
16. The American Association of Clinical Endocrinologists (2002) Medical guidelines for the management of diabetes mellitus: the AACE systems of intensive diabetes self-management-2002 update. Endocr Pract 8(Suppl 1):41-65
17. Hungarian National Center of Epidemiology (2002) National Health Survey (OLEF 2000) [article online]. Available from http://www.antsz.hu/oek/egstat/ kutat_jel.htm. Accessed 25 April 2005
18. The Nordic Medico Statistical Committee (2004) Medicine consumption in the Nordic countries 1999-2003. Nordic Medico Statistical Committee, Copenhagen
19. Charpentier G, Genes N, Vaur L, Amar J, Clerson P, Cambou JP, Gueret P (2003) Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 29: 152-158
20. Wandell EP, Gafvels C (2002) Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time. Eur J Clin Pharmacol 58:547-553
21. Shalansky SJ, Levy AR (2002) Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 36: 1532-1539
22. Grant RW, Devita NG, Singer DE, Meigs JB (2003) Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 26:1408-1412